Gentronix, a UK-based contract research organisation (CRO) working in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth. The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue transgenic mutation assay from Merck KGaA. It will be used […]